THIOPURINE METHYLTRANSFERASE DECREASED

This adverse event was reported 34 times

These drugs are most commonly taken by patients reporting THIOPURINE METHYLTRANSFERASE DECREASED:

# Drug Count
0 METHOTREXATE SODIUM 30
1 METHOTREXATE 28
2 AZATHIOPRINE 25
3 PREDNISONE 25
4 ETANERCEPT 22
5 TOCILIZUMAB 22
6 BISOPROLOL FUMARATE 21
7 DEXAMETHASONE 21
8 DEXAMETHASONE 1.5 MG 21
9 PANTOPRAZOLE 21
See all common drugs associated with THIOPURINE METHYLTRANSFERASE DECREASED

THIOPURINE METHYLTRANSFERASE DECREASED is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TOFACITINIB CITRATE 18 0.0013
1 ADALIMUMAB-AFZB 3 0.0011
2 GOLD 6 0.0010
3 ACETAMINOPHEN AND CODEINE 11 0.0009
4 INFLIXIMAB-DYYB 2 0.0006
5 TEMAZEPAM 18 0.0005
6 AZATHIOPRINE 25 0.0003
7 SUCRALFATE 5 0.0002
8 TOCILIZUMAB 22 0.0002
9 LEFLUNOMIDE 18 0.0002
See all drugs enriched for association with THIOPURINE METHYLTRANSFERASE DECREASED

THIOPURINE METHYLTRANSFERASE DECREASED is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Purine Antimetabolite [EPC] 25 0.0003
1 Aluminum Complex [EPC] 5 0.0002
2 Antirheumatic Agent [EPC] 18 0.0002
3 Interleukin-6 Receptor Antagonist [EPC] 22 0.0002
4 Selective T Cell Costimulation Modulator [EPC] 17 0.0001
5 Janus Kinase Inhibitor [EPC] 17 0.0001
6 Provitamin D2 Compound [EPC] 2 0.0001
7 Folate Analog Metabolic Inhibitor [EPC] 28 0.0001
8 Vitamin D [EPC] 19 0.0001
9 Vitamin B12 [EPC] 19 0.0001
See all drug classes enriched for association with THIOPURINE METHYLTRANSFERASE DECREASED